Back

TSLP - TSLPR signaling in immunization against atherosclerosis

30 August 2016 (10:46 - 10:55)
Organised by:
Congress Presentation Part of: The immune system in cardiovascular disease Atherosclerosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Martin Steinmetz

University clinic Knappschafts Hospital, Bochum (Germany)

5 More presentations in this session

Presentation thumbnail
An IL-6 receptor antibody suppresses IkBNS deficiency induced atherosclerosis in LDL receptor-deficient mice
Doctor K. Akita (Tokyo, JP)
Abstract
Presentation thumbnail
Hematopoietic PI3-kinase delta-deficiency causes B-1 cell depletion, impaired regulatory T-cell function and aggravated atherosclerosis in LDLR-/- mice
Doctor M. Zierden (Cologne, DE)
Abstract
Presentation thumbnail
Genetic disruption of multidrug resistance-associated protein 1 improves endothelial function and attenuates atherosclerosis in MRP1-/- LDL-/- double knockout mice.
Doctor J. Jehle (Bonn, DE)
Abstract Slides
Presentation thumbnail
Methyltransferase Set7 drives vascular inflammation and endothelial dysfunction in obesity
Doctor F. Paneni (Zurich, CH)
Abstract
Presentation thumbnail
Macrophage-derived IGF-1 contributes to aortic fibrosis and stiffening in hypertensive mice
Associate Professor G. Drummond (Bundoora, AU)
Abstract

Access the full session

Session thumbnail
The immune system in cardiovascular disease

The Event

Event poster

ESC Congress 2016

30 August 2016 10:46 CET
You may be interested in
thumbnail
Webinar
Recent advances in immune pathways in atherosclerosis
21 April 2021
thumbnail
Congress Presentation
Role of PTP1B/Ptpn1 and TCPTP/Ptpn2 in sepsis-induced cardiomyopathy
1 September 2025
thumbnail
Congress Presentation
Effect of 5-lipoxygenase-activating protein inhibiton on coronary atherosclerosis progression in patients with recent acute coronary syndrome: the PASSIVATE randomised clinical trial
1 September 2025
thumbnail
Congress Presentation
Deletion of the asialyloglycoprotein receptor-1 (ASGR1) causes atheroprotective effects in vitro and in vivo
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources